BIO

Bio-Rad Laboratories, Inc. · Healthcare · Medical - Devices
$387.70
-2.24 (-0.57%)
Mkt Cap: 10.44B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield4.5%
Dividend YieldN/A
Market Cap10.44B
Volume207.0K
Recent News
Is Bio-Rad a Buy as Digital PCR Growth Meets a Premium Valuation?
zacks.com · 2026-08-21
Bio-Rad Gains 19.1% in the Past Month: Can Its Momentum Keep Building?
zacks.com · 2026-08-20
BIO-key's Bottom Line Improves 51% on 13% Rise in Q2 Revenues Reflecting Strength with Government, Defense, and Financial Sector Customers Globally; Call Tomorrow at 10am ET
globenewswire.com · 2026-08-13
First Trust Advisors LP Has $424,000 Position in Bio-Rad Laboratories, Inc. $BIO
defenseworld.net · 2026-08-13
BIO GREEN MED SOLUTION REPORTS SECOND QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
globenewswire.com · 2026-08-12
Don't Overlook Bio-Rad (BIO) International Revenue Trends While Assessing the Stock
zacks.com · 2026-08-10

Unlock the Full Deep Scan

9 AI agents analyze BIO across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →